幹細胞市場：按類型、應用、技術、地區分類

Stem Cells Market, by Type, by Application, by Technology and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，幹細胞市場規模將達到167.8億美元，到2033年將達到312.7億美元。預計從2026年到2033年，其複合年成長率將達到9.3%。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	167.8億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	9.30%	預計金額（2033 年）	312.7億美元

幹細胞是人體的“原料”，所有其他具有特定功能的細胞都由此產生。在體內或實驗室的適當條件下，幹細胞會分裂形成稱為「子細胞」的新細胞。這些子細胞可以繼續分化成新的幹細胞，也可以分化成具有更特定功能的細胞，例如血球、腦細胞、心肌細胞或骨細胞。人體內沒有任何其他細胞具有這種天然產生新細胞類型的能力。未來，幹細胞被期望用於製造細胞和組織，以治療多種疾病，例如帕金森氏症、阿茲海默症、脊髓損傷、心臟病、糖尿病和關節炎。幹細胞與體內其他細胞的不同之處主要體現在以下三個方面：

幹細胞可以在很長一段時間內分裂和自我再生。
由於幹細胞尚未分化，因此它們無法在體內執行特定功能。
幹細胞具有分化成各種類型細胞的潛力，例如肌肉細胞、血球和腦細胞。

市場動態

科研機構研究人員活性化的研發活動正在推動全球幹細胞市場的成長。例如，2022年8月，以色列雷霍沃特魏茨曼科學研究所（一所公立研究型大學）的科學家成功地利用幹細胞培育出了具有器官前驅細胞的、可存活且能夠生長的鼠胚胎。他們完全在子宮外完成了這個過程，並藉助人工子宮使胚胎存活了八天。此前，該人工子宮曾成功維持採集的胚胎至11日齡。

本報告的主要特點

本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
本節根據各種參數（公司概況、產品系列、主要趨勢、財務表現、策略等）對全球幹細胞市場的主要公司進行介紹。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
《全球幹細胞市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球幹細胞市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

Advanced Cell Technology, Inc
Angel Biotechnology Holdings PLC
Biotricity
Lineage Cell Therapeutics, Inc.
BrainStorm Cell Limited.
CIRM
Celgene Corporation（A subsidiary of Bristol-Myers Squibb Company）
Takara Bio Inc.
Cellular Engineering Technologies.
Cytori Therapeutics Inc.
STEMCELL Technologies

第9章

分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI4222

Stem Cells Market is estimated to be valued at USD 16.78 Bn in 2026 and is expected to reach USD 31.27 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 16.78 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.30%	2033 Value Projection:	USD 31.27 Bn

Stem cells are the body's raw materials-cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells become either new stem cells or specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells, or bone cells. No other cell in the body has the natural ability to generate new cell types. Stem cells may one day be used to make cells and tissues for the therapy of many diseases. Examples include Parkinson's disease, Alzheimer's disease, spinal cord injury, heart disease, diabetes, and arthritis. Stem cells are different from other cells in the body in three ways:

Stem cells can divide and renew itself over a long period of time
Stem cells are unspecialized, so it cannot do specific functions in the body
Stem cells have the potential to become specialized cells, such as muscle cells, blood cells, and brain cells

Market Dynamics

Increasing research and development activities conducted by researchers in science institutes are contributing to the growth of the global stem cells market. For instance, in August 2022, scientists from the Weizmann Institute of Science, a public research university in Rehovot, Israel, successfully generated living, growing mouse embryos complete with organ progenitors from stem cells alone-and they did it entirely ex utero, keeping them alive for eight days with the aid of an artificial womb that previously maintained harvested embryos until they were 11 days old.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global stem cells market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Biotricity, Lineage Cell Therapeutics, Inc., BrainStorm Cell Limited., CIRM, Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company), Takara Bio Inc., Cellular Engineering Technologies., Cytori Therapeutics Inc., STEMCELL Technologies.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global stem cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cells market.

Detailed Segmentation:

Global Stem Cells Market, By Type (Revenue, USD Bn, 2021 - 2033)
Adult Stem Cells
Human Embryonic Stem Cells
Induced Pluripotent Stem Cells
Natural Rosette Cells
Very Small Embryonic Like Stem Cells
Global Stem Cells Market, By Application (Revenue, USD Bn, 2021 - 2033)
Regenerative Medicine
Drug Discovery and Development
Global Stem Cells Market, By Technology (Revenue, USD Bn, 2021 - 2033)
Cell Acquisition
Cell Production
Cryopreservation
Expansion and Sub-Culture
Global Stem Cells Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
Advanced Cell Technology, Inc.
Angel Biotechnology Holdings PLC
Biotricity
Lineage Cell Therapeutics, Inc.
BrainStorm Cell Limited.
CIRM
Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company)
Takara Bio Inc.
Cellular Engineering Technologies.
Cytori Therapeutics Inc.
STEMCELL Technologies

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By Technology
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Stem Cells Market, By Type, 2021-2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Adult Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Human Embryonic Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Induced Pluripotent Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Natural Rosette Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Very Small Embryonic Like Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

5. Global Stem Cells Market, By Application, 2021-2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

6. Global Stem Cells Market, By Technology, 2021-2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Cell Acquisition
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Cell Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Cryopreservation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Expansion and Sub-Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

7. Global Stem Cells Market, By Region, 2021-2033, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Region/Country, 2021- 2033, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Advanced Cell Technology, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Angel Biotechnology Holdings PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Biotricity
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Lineage Cell Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
BrainStorm Cell Limited.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CIRM
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Celgene Corporation (A subsidiary of Bristol-Myers Squibb Company)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Cellular Engineering Technologies.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Cytori Therapeutics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
STEMCELL Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies